BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 16724651)

  • 61. [Treatment of membranous nephropathy with chronic renal insufficiency].
    Passerini P; Leoni A
    G Ital Nefrol; 2008; 25 Suppl 44():76-82. PubMed ID: 19048590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
    Brown JH; Douglas AF; Murphy BG; Hill CM; McNamee PT; Nelson WE; Doherty CC
    Nephrol Dial Transplant; 1998 Feb; 13(2):443-8. PubMed ID: 9509460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
    Chan TM; Tse KC; Tang CS; Lai KN; Li FK
    Lupus; 2005; 14(4):265-72. PubMed ID: 15864912
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.
    Bergstein J; Leiser J; Andreoli SP
    Clin Nephrol; 1998 Jan; 49(1):9-14. PubMed ID: 9491279
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Membranous glomerulonephritis].
    Polenaković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():18-25. PubMed ID: 9102898
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C; Passerini P
    Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
    Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
    [No Abstract]   [Full Text] [Related]  

  • 70. [Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study].
    Covic A; Căruntu ID; Marian D; Volovăţ C; Ghiciuc C; Costin C; Florea L; Cotuţiu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):63-74. PubMed ID: 12089993
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
    Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A
    Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognosis and management of membraneous nephropathy.
    Pahari DK; Das S; Dutta BN; Banerjee D
    J Assoc Physicians India; 1993 Jun; 41(6):350-1. PubMed ID: 8005970
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
    Naumovic R; Furuncic D; Jovanovic D; Stosovic M; Basta-Jovanovic G; Lezaic V
    Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.